Single Isocenter Srs Using Cavmat Offers Improved Robustness To Commissioning And Treatment Delivery Uncertainty Compared To Vmat

Purpose In this study, we evaluate and compare single isocenter multiple target VMAT (SIMT) and Conformal Arc Informed VMAT (CAVMAT) radiosurgery's sensitivity to uncertainties in dosimetric leaf gap (DLG) and treatment delivery. CAVMAT is a novel planning technique that uses multiple target conformal arcs as the starting point for limited inverse VMAT optimization. Methods All VMAT and CAVMAT plans were recalculated with DLG values of 0.4, 0.8, and 1.2 mm. DLG effect on V-6Gy[cc], V-12Gy[cc], and V-16Gy[cc], and target dose was evaluated. Plans were delivered to a Delta(4) (ScandiDos, Madison, WI) phantom and gamma analysis performed with varying criteria. Log file analysis was performed to evaluate MLC positional error. Sixteen targets were delivered to a SRS MapCHECK (Sun Nuclear Corp., Melbourne, FL) to evaluate VMAT and CAVMAT's dose difference (DD) as a function of DLG. Results VMAT's average maximum and minimum target dose sensitivity to DLG was 9.08 +/- 3.50%/mm and 9.50 +/- 3.30%/mm, compared to 3.20 +/- 1.60%/mm and 4.72 +/- 1.60%/mm for CAVMAT. For VMAT, V-6Gy[cc], V-12Gy[cc], and V-16Gy[cc] sensitivity was 35.83 +/- 9.50%/mm, 34.12 +/- 6.60%/mm, and 39.23 +/- 8.40%/mm. In comparison, CAVMAT's sensitivity was 23.19 +/- 4.50%/mm, 22.45 +/- 4.40%/mm, and 24.88 +/- 4.90%/mm, respectively. Upon delivery to the Delta(4), CAVMAT offered superior dose agreement compared to VMAT. For a 1%/1 mm gamma analysis, VMAT and CAVMAT had a passing rate of 94.53 +/- 4.40% and 99.28 +/- 1.70%, respectively. CAVMAT was more robust to DLG variation, with the SRS MapCHECK plans yielding an absolute average DD sensitivity of 2.99 +/- 1.30%/mm compared to 5.07 +/- 1.10%/mm for VMAT. Log files demonstrated minimal differences in MLC positional error for both techniques. Conclusions CAVMAT remains robust to delivery uncertainties while offering a target dose sensitivity to DLG less than half that of VMAT, and 65% of that of VMAT for V-6Gy[cc], V-12Gy[cc], and V-16Gy[cc]. The superior dose agreement and reduced sensitivity of CAVMAT to DLG uncertainties indicate promise as a robust alternative to VMAT for SIMT SRS.